Monte Rosa Therapeutics, Inc.股价上涨14.16% 市值涨3827.96万美元

市场透视2025-05-08

北京时间2025年05月08日21时34分，Monte Rosa Therapeutics, Inc.（GLUE.us）股票出现异动，股价快速上涨14.16%。截至发稿，该股报4.40美元/股，成交量1.8711万股，换手率0.03%，振幅7.92%。最近的财报数据显示，该股实现营业收入75.62百万美元，净利润-72.70百万美元，每股收益-0.98美元，毛利67.50百万美元，市盈率-4.48...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2533136323?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-08 21:34","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2533136323","market":"us","top_or_hot":-1,"title":"Monte Rosa Therapeutics, Inc.股价上涨14.16% 市值涨3827.96万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年05月08日21时34分，Monte Rosa Therapeutics, Inc.（GLUE.us）股票出现异动，股价快速上涨14.16%。截至发稿，该股报4.40美元/股，成交量1.8711万股，换手率0.03%，振幅7.92%。最近的财报数据显示，该股实现营业收入75.62百万美元，净利润-72.70百万美元，每股收益-0.98美元，毛利67.50百万美元，市盈率-4.48...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213415a6d7c45f&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Monte Rosa Therapeutics, Inc.股价上涨14.16% 市值涨3827.96万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMonte Rosa Therapeutics, Inc.股价上涨14.16% 市值涨3827.96万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-08 21:34 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213415a6d7c45f&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月08日21时34分，Monte Rosa Therapeutics, Inc.（GLUE.us）股票出现异动，股价快速上涨14.16%。截至发稿，该股报4.40美元/股，成交量1.8711万股，换手率0.03%，振幅7.92%。最近的财报数据显示，该股实现营业收入75.62百万美元，净利润-72.70百万美元，每股收益-0.98美元，毛利67.50百万美元，市盈率-4.48...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213415a6d7c45f&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213415a6d7c45f&s=b","article_id":"2533136323","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213415a6d7c45f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2533136323","pubTimestamp":1746711254,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月08日21时34分，Monte Rosa Therapeutics, Inc.股票出现异动，股价快速上涨14.16%。Monte Rosa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.43%。Monte Rosa Therapeutics, Inc.公司简介：Monte Rosa Therapeutics Inc 是一家生物技术公司，专门开发分子胶降解剂，这是一类利用人体天然蛋白质破坏机制选择性降解治疗相关蛋白质的小分子药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4539":"次新股","LENZ":"Therapeutics","BK4139":"生物科技","BK4007":"制药","GLUE":"Monte Rosa Therapeutics"},"translate_title":"Monte Rosa Therapeutics, Inc. stock rose 14.16%, market capitalization rose $38.2796 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"GLUE":1},"content_text":"北京时间2025年05月08日21时34分，Monte Rosa Therapeutics, Inc.（GLUE.us）股票出现异动，股价快速上涨14.16%。截至发稿，该股报4.40美元/股，成交量1.8711万股，换手率0.03%，振幅7.92%。最近的财报数据显示，该股实现营业收入75.62百万美元，净利润-72.70百万美元，每股收益-0.98美元，毛利67.50百万美元，市盈率-4.48倍。机构评级方面，在所有9家参与评级的机构中，89%的券商给予买入建议，11%的券商给予持有建议，无券商给予卖出建议。Monte Rosa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.43%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 (To Pur Com)、Autolus Therapeutics Plc、诺瓦瓦克斯医药涨幅较大，Nucana Plc、Gri Bio, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为281.71%、42.65%、15.44%，振幅较大的相关个股有Vor Biopharma Inc.、Zenas Biopharma, Inc.、诺瓦瓦克斯医药，振幅分别为17.83%、14.22%、11.27%。Monte Rosa Therapeutics, Inc.公司简介：Monte Rosa Therapeutics Inc 是一家生物技术公司，专门开发分子胶降解剂（MGDs），这是一类利用人体天然蛋白质破坏机制选择性降解治疗相关蛋白质的小分子药物。利用 QuEEN 平台，该公司采用人工智能和专有实验工具来识别 MGD 降解的目标蛋白质。拥有超过 50,000 个 MGD 分子的多样化文库，他们最先进的候选产品——MRT-2359，针对可用于 MYC 驱动的肿瘤的，翻译终止因子蛋白 GSPT1。 该公司的重点在于推进其 MGD 产品，旨在为各种疾病提供新颖的治疗方式。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2533136323","isCrawlerRequest":true}